Nu Skin Enterprises Announces Executive and Board Changes

Ticker: NUS · Form: 8-K · Filed: 2025-03-06T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, board-changes, governance

TL;DR

NU SKIN shakes up exec team & board, effective March 5.

AI Summary

Nu Skin Enterprises, Inc. announced on March 5, 2025, a series of executive and board changes. These include the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key executives. The filing details these changes as of March 5, 2025.

Why It Matters

Changes in leadership and board composition can signal shifts in company strategy, governance, or future performance.

Risk Assessment

Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational stability.

Key Players & Entities

FAQ

What specific roles have been affected by the departures of officers or directors?

The filing indicates departures of certain officers and directors but does not specify the exact roles in this summary section.

Who are the newly elected directors?

The filing mentions the election of directors but does not list their names in the provided text.

What are the key changes in compensatory arrangements for officers?

The filing notes adjustments to compensatory arrangements for certain officers, but the specifics are not detailed here.

What is the effective date of these reported changes?

The earliest event reported is dated March 5, 2025.

What is Nu Skin Enterprises, Inc.'s primary business classification?

Nu Skin Enterprises, Inc. is classified under WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122].

From the Filing

0001140361-25-007278.txt : 20250306 0001140361-25-007278.hdr.sgml : 20250306 20250306060457 ACCESSION NUMBER: 0001140361-25-007278 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250305 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250306 DATE AS OF CHANGE: 20250306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 25713502 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 8-K 1 ef20044848_8k.htm FORM 8-K false 0001021561 0001021561 2025-03-05 2025-03-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 5, 2025   Date of Report (Date of earliest event reported)     NU SKIN ENTERPRISES, INC.     (Exact name of registrant as specified in its charter)   Delaware   001-12421   87-0565309 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification Number)   75 West Center Street Provo , Utah 84601     (Address of principal executive offices and zip code)     ( 801 ) 345-1000     (Registrant’s telephone number, including area code)     N/A     (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $.001 par value NUS New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 5, 2025, Zheqing (Simon) Shen informed Nu Skin Enterprises, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) at the Company’s 2025 Annual M

View on Read The Filing